title: Characteristics of tumor infiltration by adoptively transferred and endogenous natural-killer cells in a syngeneic rat model: implications for the mechanism behind anti-tumor responses.
abstract: Interleukin-2-activated, cultured NK cells (A-NK) cells were adoptively transferred into a syngeneic rat liver-tumor model. The kinetics of tumor infiltration by NK cells, originating either from adoptively transferred or from endogenous sources, the localization of these cells in the tumor, and their interactions with extracellular-matrix proteins were studied by immunohistochemistry and transmission-electron microscopy. The adoptive transfer of A-NK cells via the hepatic artery and s.c. injections of IL-2 into rats bearing subcapsularly induced CC531 liver tumors, but also IL-2 monotherapy, resulted in a significant increase of the number of NK cells both at the tumor border and in the tumor center. The majority of tumor-infiltrating NK cells was present in the tumor stroma and only occasionally was an NK cell observed in a tumor nodule in direct contact with tumor cells. Observations by electron microscopy suggested that matrix proteins, abundantly present in the tumor stroma but absent in the tumor nodules, provide a substrate for migration of infiltrating cells, whereas tight structures of matrix proteins surrounding tumor nodules provide a barrier for establishment of direct NK-cell-to-tumor-cell-contact. Our results suggest that direct NK-cell-to-target-cell-contact-mediated lysis is of minor importance for attaining an anti-tumor effect in this model. We hypothesize that treatment of tumor-bearing rats with A-NK cells and/or IL-2 initiates a cascade of events (e.g., secretion of tumor-killing cytokines and/or infiltration of other immune cells) ultimately leading to tumor regression.
authors.affiliation: Department of Surgery, Leiden University Medical Center, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Hagenaars
authors.forename: S
authors.initials: S
authors.lastname: Zwaveling
authors.forename: P J
authors.initials: PJ
authors.lastname: Kuppen
authors.forename: N G
authors.initials: NG
authors.lastname: Ensink
authors.forename: A M
authors.initials: AM
authors.lastname: Eggermont
authors.forename: M E
authors.initials: ME
authors.lastname: Hokland
authors.forename: P H
authors.initials: PH
authors.lastname: Basse
authors.forename: C J
authors.initials: CJ
authors.lastname: van de Velde
authors.forename: G J
authors.initials: GJ
authors.lastname: Fleuren
authors.forename: U
authors.initials: U
authors.lastname: Nannmark
mesh_terms: D019264:Adoptive Transfer; D000818:Animals; D006098:Granulocytes / Q000276:immunology; D007150:Immunohistochemistry; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000276:immunology / Q000637:transplantation*; D007700:Kinetics; D008113:Liver Neoplasms / Q000276:immunology* / Q000473:pathology; D008213:Lymphocyte Activation; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008297:Male; D008854:Microscopy, Electron; D009368:Neoplasm Transplantation; D051381:Rats; D011919:Rats, Inbred Strains; D014407:Tumor Cells, Cultured
chemical_list: D007376:Interleukin-2